Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis.

Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9.

2.

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo.

Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marín-Padilla M, Sharpe AH, Speck NA.

Cell. 1996 Nov 15;87(4):697-708.

3.

Core-binding factor: a central player in hematopoiesis and leukemia.

Speck NA, Stacy T, Wang Q, North T, Gu TL, Miller J, Binder M, Marín-Padilla M.

Cancer Res. 1999 Apr 1;59(7 Suppl):1789s-1793s. Review.

PMID:
10197598
4.
5.

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marín-Padilla M, Tenen DG, Speck NA, Zhang DE.

Nat Genet. 1997 Mar;15(3):303-6.

PMID:
9054947
6.

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis.

Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR.

Cell. 1996 Jan 26;84(2):321-30.

8.

Cbfa2 is required for the formation of intra-aortic hematopoietic clusters.

North T, Gu TL, Stacy T, Wang Q, Howard L, Binder M, Marín-Padilla M, Speck NA.

Development. 1999 Jun;126(11):2563-75.

9.

Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.

Sasaki K, Yagi H, Bronson RT, Tominaga K, Matsunashi T, Deguchi K, Tani Y, Kishimoto T, Komori T.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12359-63.

10.
11.
12.
13.

CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy.

Roulston D, Espinosa R 3rd, Nucifora G, Larson RA, Le Beau MM, Rowley JD.

Blood. 1998 Oct 15;92(8):2879-85.

14.

Transcription factors that regulate growth and differentiation of myeloid cells.

Nagamura-Inoue T, Tamura T, Ozato K.

Int Rev Immunol. 2001 Feb;20(1):83-105. Review.

PMID:
11342299
15.

Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2.

Takahashi A, Satake M, Yamaguchi-Iwai Y, Bae SC, Lu J, Maruyama M, Zhang YW, Oka H, Arai N, Arai K, et al.

Blood. 1995 Jul 15;86(2):607-16.

16.

Lethal beta-thalassaemia in mice lacking the erythroid CACCC-transcription factor EKLF.

Perkins AC, Sharpe AH, Orkin SH.

Nature. 1995 May 25;375(6529):318-22.

PMID:
7753195
17.
18.

Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development.

Satake M, Nomura S, Yamaguchi-Iwai Y, Takahama Y, Hashimoto Y, Niki M, Kitamura Y, Ito Y.

Mol Cell Biol. 1995 Mar;15(3):1662-70.

19.
20.

Dysplastic definitive hematopoiesis in AML1/EVI1 knock-in embryos.

Maki K, Yamagata T, Asai T, Yamazaki I, Oda H, Hirai H, Mitani K.

Blood. 2005 Sep 15;106(6):2147-55.

Items per page

Supplemental Content

Support Center